Please provide your email address to receive an email when new articles are posted on . Adults with acromegaly are more likely to have hypertension, diabetes and other comorbidities than healthy ...

Please provide your email address to receive an email when new articles are posted on . Real-world data from the long-term ACROSTUDY show the growth hormone receptor antagonist pegvisomant is safe and ...

Debiopharm has randomised the first patient in the global Phase III clinical trial, OXTEND-III, to assess the safety and ...

When Ray Kohn started feeling pain in his knees and elbows in 2015, he attributed it to his work as a stunt driver and mechanic. But as the years went on, he began to notice his body changing in ...

Acromegaly is one of those diseases that immediately caught our attention when we first heard about it in medical school. We stared at the textbook pictures of big hands and coarse faces—maybe a very ...

A personalized treatment protocol was more effective for management of acromegaly -- also known as gigantism -- than the usual trial-and-error approach, the ...

Discover top medications for 'treating Acromegaly'? This page compiles essential information on generic and brand-name drugs specifically used for Acromegaly treatment.Here, you can explore dosages, ...

Acromegaly is an endocrine disorder where there is a hormonal imbalance in the body. The condition is caused by too much growth hormone (GH). Growth hormone is normally produced by the pituitary gland ...

A: Gigantism is the excessive secretion of growth hormone during childhood causing overgrowth of long bones and very tall stature. Q: Is Acromegaly a fatal disease? A: Acromegaly itself is usually not ...

Available medical therapies for acromegaly are limited by moderate and variable efficacy, the need for life-long monthly intramuscular and/or deep subcutaneous depot, or thrice-daily subcutaneous ...

Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Acromegaly and Gigantism - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The acromegaly ...